Johnson & Johnson JNJ
Quarterly report 2024-Q3
added 10-23-2024
Country |
USA |
IPO year |
- |
Industry |
Drug manufacturers |
Stock Exchange |
NYSESPB |
CEO |
Mr. Alex Gorsky |
Employees in the company |
132 200 |
Shares |
2.53 B |
Market Cap[1] |
$ 367 B |
EBITDA (LTM) |
$ 9.42 B |
P/E (LTM) |
11.25 |
P/S (LTM) |
4.79 |
EPS (LTM) |
14.74 |
Johnson & Johnson is a multinational corporation that specializes in healthcare products, medical devices, and pharmaceuticals. Founded in 1886, the company has grown to become one of the largest healthcare companies in the world, with operations in over 60 countries.
The company's products are used by millions of people every day, from baby shampoo and band-aids to prescription drugs and surgical equipment. Some of its most well-known brands include Tylenol, Neutrogena, and Listerine.
Johnson & Johnson is committed to improving the health and well-being of people around the world. The company invests heavily in research and development, with a focus on finding new treatments for diseases such as cancer, Alzheimer's, and HIV/AIDS.
In addition to its healthcare products, Johnson & Johnson is also known for its commitment to corporate social responsibility. The company has a long history of supporting various charitable causes, including disaster relief efforts and global health initiatives.
Overall, is a trusted and respected leader in the healthcare industry, with a strong track record of innovation and social responsibility.
Other stocks of industry "Drug manufacturers"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.